Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May;26(5):1068-1071.
doi: 10.1111/codi.16991. Epub 2024 Apr 12.

The conundrum of total neoadjuvant therapy in rectal cancer

Devesh S Ballal  1 , Tejas P Vispute  2 , Avanish P Saklani  2
Affiliations
Review

The conundrum of total neoadjuvant therapy in rectal cancer

Devesh S Ballal et al. Colorectal Dis. 2024 May.

Abstract

Total neoadjuvant therapy (TNT) has fast become the paradigm in the management of rectal cancer. The widespread adoption of this approach across the world, not only for locally advanced cancers but even for cancers that otherwise would not merit chemotherapy, leads both to an increase in treatment-related toxicity for patients and burdens the healthcare services of the country. It is important to tailor treatment to each patient based not only on the tumour but, even more importantly, on the patient's expectations and goals. The intent of treatment while prescribing TNT needs to be clear, understanding that not all patients are suitable for an organ preservation (watch and wait) approach and that the survival benefits of TNT are not as obvious as most proponents believe.

Keywords: rectal cancer; total neoadjuvant therapy; watch and wait.

PubMed Disclaimer

References

REFERENCES

    1. Conroy T, Bosset JF, Etienne PL, Rio E, François É, Mesgouez‐Nebout N, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER‐PRODIGE 23): a multicentre, randomised, open‐label, phase 3 trial. Lancet Oncol. 2021;22(5):702–715. https://doi.org/10.1016/S1470‐2045(21)00079‐6
    1. Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EMK, et al. Short‐course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open‐label, phase 3 trial. Lancet Oncol. 2021;22(1):29–42. https://doi.org/10.1016/S1470‐2045(20)30555‐6
    1. Schrag D, Shi Q, Weiser MR, Gollub MJ, Saltz LB, Musher BL, et al. Preoperative treatment of locally advanced rectal cancer. N Engl J Med. 2023;389(4):322–334. https://doi.org/10.1056/NEJMOA2303269/SUPPL_FILE/NEJMOA2303269_DATA‐SHAR...
    1. Brown G, Daniels IR. Preoperative staging of rectal cancer: the MERCURY research project. Recent Results Cancer Res. 2005;165:58–74. https://doi.org/10.1007/3‐540‐27449‐9_8
    1. Unuvar M, Blansfield J, Wang S, Hoffman RL. Trends in adoption of total neoadjuvant therapy for locally advanced rectal cancer. Am J Surg. 2024;227:229–236. https://doi.org/10.1016/j.amjsurg.2023.10.028

LinkOut - more resources